PL336206A1 - Method of preventing mammary carcinoma by means of selective modulators of oestrogen receptors - Google Patents
Method of preventing mammary carcinoma by means of selective modulators of oestrogen receptorsInfo
- Publication number
- PL336206A1 PL336206A1 PL98336206A PL33620698A PL336206A1 PL 336206 A1 PL336206 A1 PL 336206A1 PL 98336206 A PL98336206 A PL 98336206A PL 33620698 A PL33620698 A PL 33620698A PL 336206 A1 PL336206 A1 PL 336206A1
- Authority
- PL
- Poland
- Prior art keywords
- mammary carcinoma
- selective modulators
- oestrogen receptors
- preventing mammary
- preventing
- Prior art date
Links
- 201000008275 breast carcinoma Diseases 0.000 title 1
- 239000000262 estrogen Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/64—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4311897P | 1997-04-09 | 1997-04-09 | |
| PCT/US1998/006989 WO1998045286A1 (en) | 1997-04-09 | 1998-04-07 | Prevention of breast cancer with selective estrogen receptor modulators |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL336206A1 true PL336206A1 (en) | 2000-06-05 |
Family
ID=21925594
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL98336206A PL336206A1 (en) | 1997-04-09 | 1998-04-07 | Method of preventing mammary carcinoma by means of selective modulators of oestrogen receptors |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0975628A4 (en) |
| JP (1) | JP2001518897A (en) |
| KR (1) | KR20010006215A (en) |
| CN (1) | CN1259945A (en) |
| AU (1) | AU6957398A (en) |
| CA (1) | CA2286207A1 (en) |
| EA (1) | EA199900910A1 (en) |
| HU (1) | HUP0001845A2 (en) |
| ID (1) | ID23653A (en) |
| IL (1) | IL132279A0 (en) |
| NO (1) | NO994902L (en) |
| PL (1) | PL336206A1 (en) |
| TR (1) | TR199903244T2 (en) |
| WO (1) | WO1998045286A1 (en) |
| ZA (1) | ZA982818B (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6653479B1 (en) | 1999-07-29 | 2003-11-25 | Eli Lilly And Company | Crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b] thiophene hydrochloride |
| US6610706B1 (en) | 1999-07-29 | 2003-08-26 | Eli Lilly And Company | Crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene hydrochloride |
| NZ585389A (en) | 2007-10-16 | 2011-10-28 | Repros Therapeutics Inc | Trans-clomiphene for metabolic syndrome |
| ES2681023T3 (en) | 2012-02-29 | 2018-09-11 | Repros Therapeutics Inc. | Combination therapy to treat androgen deficit |
| ES2671516T3 (en) | 2013-02-19 | 2018-06-06 | Novartis Ag | Benzothiophene derivatives and compositions thereof as selective estrogen receptor degraders |
| GB201311888D0 (en) * | 2013-07-03 | 2013-08-14 | Glaxosmithkline Ip Dev Ltd | Novel compounds |
| US11633382B2 (en) | 2015-11-10 | 2023-04-25 | Paracrine Therapeutics Ab | Treatment of ER-negative breast cancer with an PDGF-CC inhibitor and anti-estrogen |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5510357A (en) * | 1995-02-28 | 1996-04-23 | Eli Lilly And Company | Benzothiophene compounds as anti-estrogenic agents |
| JP3989569B2 (en) * | 1995-02-28 | 2007-10-10 | イーライ リリー アンド カンパニー | Benzothiophene compounds, intermediates, compositions and methods |
| US5731342A (en) * | 1996-02-22 | 1998-03-24 | Eli Lilly And Company | Benzothiophenes, formulations containing same, and methods |
-
1998
- 1998-04-02 ZA ZA9802818A patent/ZA982818B/en unknown
- 1998-04-07 CN CN98805957A patent/CN1259945A/en active Pending
- 1998-04-07 IL IL13227998A patent/IL132279A0/en unknown
- 1998-04-07 EA EA199900910A patent/EA199900910A1/en unknown
- 1998-04-07 AU AU69573/98A patent/AU6957398A/en not_active Abandoned
- 1998-04-07 EP EP98915368A patent/EP0975628A4/en not_active Withdrawn
- 1998-04-07 TR TR1999/03244T patent/TR199903244T2/en unknown
- 1998-04-07 PL PL98336206A patent/PL336206A1/en unknown
- 1998-04-07 HU HU0001845A patent/HUP0001845A2/en unknown
- 1998-04-07 CA CA002286207A patent/CA2286207A1/en not_active Abandoned
- 1998-04-07 ID IDW991189A patent/ID23653A/en unknown
- 1998-04-07 KR KR1019997009295A patent/KR20010006215A/en not_active Withdrawn
- 1998-04-07 WO PCT/US1998/006989 patent/WO1998045286A1/en not_active Ceased
- 1998-04-07 JP JP54309098A patent/JP2001518897A/en active Pending
-
1999
- 1999-10-08 NO NO994902A patent/NO994902L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ID23653A (en) | 2000-05-11 |
| KR20010006215A (en) | 2001-01-26 |
| CN1259945A (en) | 2000-07-12 |
| EA199900910A1 (en) | 2000-04-24 |
| NO994902L (en) | 1999-12-07 |
| IL132279A0 (en) | 2001-03-19 |
| WO1998045286A1 (en) | 1998-10-15 |
| NO994902D0 (en) | 1999-10-08 |
| AU6957398A (en) | 1998-10-30 |
| ZA982818B (en) | 1999-10-04 |
| CA2286207A1 (en) | 1998-10-15 |
| EP0975628A4 (en) | 2001-03-21 |
| JP2001518897A (en) | 2001-10-16 |
| HUP0001845A2 (en) | 2001-06-28 |
| TR199903244T2 (en) | 2000-05-22 |
| EP0975628A1 (en) | 2000-02-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0971588A4 (en) | Novel cannabinoid receptor modulators | |
| EP0998021A4 (en) | Thermostatically controlled quartz generator | |
| GB2330995B (en) | Communication apparatus for digital communication | |
| FI951780L (en) | Method for preparing catalyst components | |
| GB9715241D0 (en) | Device for treating aneurysms | |
| IL126525A0 (en) | Method for admitting new connections | |
| IL126524A0 (en) | Method for admitting new connections | |
| IL133822A0 (en) | Aroylpiperazines for modulating sexual activity | |
| AU133621S (en) | Telecommunication apparatus | |
| AU4425399A (en) | Novel therapeutic agents that modulate 5-ht receptors | |
| PL336206A1 (en) | Method of preventing mammary carcinoma by means of selective modulators of oestrogen receptors | |
| GB9506946D0 (en) | Microgels | |
| ZA961172B (en) | Open cast mining apparatus. | |
| ZA985308B (en) | Irrigation method | |
| IL122557A0 (en) | Cytoplasmic modulators of integrin regulation/signaling | |
| GB9826806D0 (en) | Excavation apparatus | |
| IL134507A0 (en) | Method for preparing oxazaphosphorin-2-amines | |
| ZA956099B (en) | Method of establishing tonic ovarian estrogen secretion for extended therapeutic regimens. | |
| AU3499997A (en) | Method of using ligands of the kappa opioid receptor | |
| FI960382L (en) | Method for implementing packet-based communication | |
| GB9721633D0 (en) | Communication apparatus | |
| TW329950U (en) | Detectaphone device for modulating serial communication | |
| IL130583A (en) | Liquid development apparatus | |
| AU126477S (en) | Communication apparatus | |
| GB9803076D0 (en) | Telecommunication apparatus |